top of page
Open Site Navigation
Stuart Marcus

Stuart Marcus

Founder, CMO and CSO

Stuart pioneered the development of Photodynamic Therapy Systems, with over 30 years of experience with ALA.

Mark de Souza

Mark de Souza

President and CEO

Mark has over 20 years of executive and entrepreneurial experience in the rare disease space.

Nandini Kandolha

Nandini Kandolha

CFO and COO

Nandini is an experienced financial and strategic leader with over 15 years of experience in finance, accounting, audit, strategy and team building.

Joanne LaValle

Joanne LaValle

Vice President, Regulatory Affairs

Joanne has over 25 years of experience in Regulatory Affairs and Pharmacovigilance focused on drug, device and combination product development and commercialization.

Ramei Sani-Grosso

Ramei Sani-Grosso

Senior Vice President, Clinical Operations

Ramei has over 26 years of industry experience in drug development in oncology, rare/orphan disease, and vaccines.

Jacqueline Kuritzky

Jacqueline Kuritzky

Senior Director, Clinical Operations

Jacquie has over 30 years of clinical operations experience, including 11 years at Regeneron.

April Freeman

April Freeman

Director, Patient Advocacy & Engagement

April has over 15 years of experience in patient advocacy and public policy.

Sudheer Swamy

Sudheer Swamy

Director, Project Management

Sudheer has over 15 years of project leadership experience in biotech and healthcare tech.

Kanthi Gunturi

Kanthi Gunturi

Assistant Controller

Kanthi has over 15 years of experience in accounting and finance.

Michael Bellas

Michael Bellas

Assistant Manager, Business Development & Operations

Michael graduated from the University of California, Berkeley, where he received a degree in genetics and data science.

Kathryn Rosengrant

Kathryn Rosengrant

Regulatory Affairs Associate

Katie has a background in computer science and has been supporting SonALAsense operations since 2019.

Carolina Brekke

Carolina Brekke

Office Manager

Carolina has over 15 years of experience as an office manager and administrative assistant.

Kat Sampel-Morris

Kat Sampel-Morris

Clinical Trial Assistant

Kat has over 15 years of experience in clinical research trials.

Brian Roden

Brian Roden

CMC Advisor

Brian is a research chemist with 25+ years experience in the development of branded and generic pharmaceutical products.

Brian Rogers

Brian Rogers

Non-Clinical Advisor

Brian has nearly 30 years of industrial toxicology experience, including over 25 years in the biotechnology and pharmaceutical industries.

Katherine York

Katherine York

HR

Katherine has over 10 years of experience in human resources and talent management.

Sean Corzine

Sean Corzine

Assistant Manager, IT

Sean has a degree in Computer Science and has a background in data science.

Leading our Mission

SonALAsense is led by an experienced leadership team and Scientific Advisory Board and is the first company to advance sonodynamic therapy into Phase 2 clinical trials. Our leadership has developed multiple drugs and drug-device combination therapies through FDA approval, creating the perfect team to advance Sonodynamic Therapy from bench to bedside. This team has successfully worked together for years, and, in some cases, decades.

Mitchel S. Berger, MD

Professor of Neurological Surgery and Director, Brain Tumor Center, University of California, San Francisco

Pejman Ghanouni, MD, PhD

Associate Professor, Radiology, Stanford University School of Medicine

Stuart L. Marcus, MD, PhD

Founder, Chief Medical Officer and Chief Scientific Officer, SonALAsense

Scott R. Plotkin, MD, PhD

Armenise Harvard Professor of Neurology, Harvard Medical School, Chief, Division of Neuro-Oncology, Massachusetts General Hospital

Graeme F. Woodworth, MD

Professor and Chair, Department of Neurosurgery, Director of the Brain Tumor Treatment & Research Center, University of Maryland School of Medicine

Margaret Dugan, MD

CMO, Dracen Pharmaceuticals, Former Senior VP & Global Program Head, Novartis Oncology

Robert Scott, MBBS

Emeritus Professor for Royal College of Ophthalmologists and Defence Medical Services

Stuart L. Marcus, MD, PhD

Founder, CMO and CSO

Mark P. de Souza, PhD

President and CEO

Vincent Sai

CEO and Partner, Modality Partnership

The SonALAsense Scientific Advisory Board

The SonALAsense Board of Directors

The SonALAsense Team

bottom of page